FIELD: medicine.
SUBSTANCE: invention refers to medical products and concerns a pharmaceutical tablet, contains a therapeutically effective dose of crystalline telmisartan sodium salt of fusion temperature 245±5°C and diuretic hydrochlorothiaside, as well as one or more adjuvants used to prepare medical products. There is also disclosed method for making thereof. According to the invention, the pharmaceutical tablets are storage-stable.
EFFECT: intended for prevention or treatment of diseases wherein application of angiotensin II antagonists ensures the therapeutic effect.
23 cl, 7 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTI-LAYERED TABLET, CONTAINING EFFERVESCENT LAYER | 2010 |
|
RU2547562C2 |
| COMPOSITION OF SOLID QUICK-DISINTEGRATING TABLET | 2008 |
|
RU2472493C2 |
| SOLID DOSAGE FORM | 2004 |
|
RU2377987C2 |
| SOLID MEDICATION OF OLMESARTAN MEDOXOMIL AND AMLODIPINE | 2007 |
|
RU2423975C2 |
| IRBESARTAN-CONTAINING PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2465900C2 |
| ORAL MEDICINAL FORMULATION WHICH IS SOLUBLE IN LARGE BOWEL AND AN ENVELOPE MATERIAL FOR ITS | 1993 |
|
RU2116785C1 |
| ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2593939C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FIMASARTAN AND HYDROCHLOROTHIAZIDE | 2013 |
|
RU2613900C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITOR OF HMG-REDUCTASE | 2000 |
|
RU2206324C1 |
| COMPOSITIONS OF TELMISARTAN IN FORM OF NANOPARTICLES, AND METHOD FOR PREPARING THEM | 2010 |
|
RU2526914C2 |
